FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to endocrinology, and can be used for treating hypothyroidism in autoimmune thyroiditis. That is ensured by administering dalargin 0.1% solution in dose of 1.0 ml intramuscularly 2 times day for 20 days in courses every 3 months, 4 courses in total.
EFFECT: invention provides highly effective treatment of hypothyroidism in autoimmune thyroiditis, restoration of thyroid function.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
METHOD OF TREATING DIABETES MELLITUS IN COMPLEX WITH DALARGIN | 2023 |
|
RU2816021C1 |
METHOD OF TREATING CHRONIC KIDNEY DISEASE WITH DALARGIN | 2023 |
|
RU2819638C1 |
METHOD OF TREATING CLIMACTERIC SYNDROME IN WOMEN | 2024 |
|
RU2821826C1 |
METHOD OF TREATING HASHIMOTO DISEASE | 2009 |
|
RU2410089C1 |
METHOD OF TREATING KNEE OSTEOARTHRITIS | 2024 |
|
RU2822321C1 |
METHOD OF TREATING THYROID GLAND DISEASES ACCOMPANIED BY HYPOTHYROIDISM | 2008 |
|
RU2405561C2 |
METHOD OF TAKING PREVENTIVE MEASURES AIMED AT TREATMENT OF THYROID GLAND DISEASES IN CHILDREN OF EARLY AGE BORN FROM MOTHERS WITH OPPORTUNISTIC INFECTIONS | 2007 |
|
RU2355447C1 |
METHOD FOR ESTIMATING AUTOIMMUNE THYROIDITIS TREATMENT EFFECTIVENESS | 2006 |
|
RU2323443C1 |
METHOD AND MEANS OF LIPS OF MOUTH CORRECTION | 2023 |
|
RU2825521C1 |
Authors
Dates
2024-03-04—Published
2023-11-12—Filed